Log In
Print
BCIQ
Print
Print this Print this
 

MammaPrint

  Manage Alerts
Collapse Summary General Information
Company Agendia N.V.
DescriptionBreast cancer prognostic test using a 70-gene signature chip
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsBreast cancer prognosis and prediction for <61 yr patients; Predict prognosis of patients with HER2-positive patients; Predict prognosis of patients with node-negative breast cancer; Predict response to neoadjuvant chemotherapy in breast cancer patients; Predict the risk of breast cancer recurrence; Predict the risk of metastases in breast cancer patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today